Related references
Note: Only part of the references are listed.Short, Highly Effective, and Inexpensive Standardized Treatment of Multidrug-resistant Tuberculosis
Armand Van Deun et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Pyrazinamide resistance in multidrug-resistant Mycobacterium tuberculosis isolates in Japan
H. Ando et al.
CLINICAL MICROBIOLOGY AND INFECTION (2010)
Epidemiology and clinical management of XDR-TB: a systematic review by TBNET
G. Sotgiu et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial
Marcus B. Conde et al.
LANCET (2009)
Treatment Outcomes of Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis
James C. Johnston et al.
PLOS ONE (2009)
Development and evaluation of a line probe assay for rapid identification of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis strains
Jun-Ichiro Sekiguchi et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Detection of multidrug resistance in Mycobacterium tuberculosis
Jun-ichiro Sekiguchi et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Empirical treatment with a fluoroquinolone delays the treatment for tuberculosis and is associated with a poor prognosis in endemic areas
J-Y Wang et al.
THORAX (2006)
Novel gyrase mutations in quinolone-resistant and -hypersusceptible clinical isolates of Mycobacterium tuberculosis: Functional analysis of mutant enzymes
A Aubry et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)